Dr Matthew Norton,head of policy at Alzheimer's Research UK, welcomes a recent drug that slows the pace of mental decline. The drug, and called solanezumab,is shown to stave off memory loss in patients with mild Alzheimer's over the course of several years. It is the first time any medicine has slowed the rate at which the disease damages the brain Continue reading...
Source: theguardian.com